trial · primary record
TCRαβ+/CD19+ depleted Haploidentical HSCT
Acute Myeloid Leukemia
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 22 |
| Primary completion | 2027-12 |
| Primary endpoint | Incidence of acute graft versus host disease (GVHD) |
| Registry ID | NCT02508038 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T03:28:08.796Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT02508038
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.